J KEVIN BUCHI Insider Trading $TLOG TETRALOGIC PHARMACEUTICALS Corp

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for J KEVIN BUCHI.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of J KEVIN BUCHI. J KEVIN BUCHI is Chief Executive Officer in BIOSPECIFICS TECHNOLOGIES CORP ($BSTCE) and Director in IMPAX LABORATORIES INC ($IPXL) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and Director in STEMLINE THERAPEUTICS INC ($STML) and Director in Alexza Pharmaceuticals Inc. ($ALXA) and President & CEO in TETRALOGIC PHARMACEUTICALS CORP ($TLOG) and in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Amneal Pharmaceuticals, Inc. ($AMRX).

J KEVIN BUCHI in TETRALOGIC PHARMACEUTICALS Corp

Trading Symbol: TLOG
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J KEVIN BUCHI: President & CEO
Holdings: 330,714 shares
Current Value: $19,843
Latest Transaction: Mar 30 2015
$TLOG Market Capitalization: $1.49M
$TLOG Previous Close: $0.06

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of J KEVIN BUCHI in TETRALOGIC PHARMACEUTICALS Corp

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALXA, AMRX, BSTCE, DRNA, CRXX, IPXL, STML, TLOG, ZIOP

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 30 2015TLOGTETRALOGIC PHARMAC ...BUCHI J KEVINPresident & CEOBuyP4.235,00021,148330,714325.7 K to 330.7 K (+1.54 %)

Page:   1